Spyre Therapeutics (SYRE) Receivables - Accured (2019 - 2026)
Spyre Therapeutics (SYRE) recorded Receivables - Accured of $5.8 million in Q2 2026, up 65.7% from $3.5 million a year earlier and up 26.1% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Receivables - Accured (2019 - 2026) Analysis & Trends
At the end of FY2025, Spyre Therapeutics reported Receivables - Accured of $4.5 million, up 32.4% from FY2024.
- Annual Receivables - Accured has increased for three straight years, with a five-year compound annual growth rate of 86.4% (FY2020 to FY2025).
- Across earlier years, Receivables - Accured came in at $3.4 million in FY2024 (+277.8%), $900,000 in FY2023 (+800.0%), $100,000 in FY2022 (unchanged) and $100,000 in FY2021 (-50.0%).
- The Q2 2026 figure is the highest quarterly Receivables - Accured in data going back to Q4 2019.
- On a year-over-year basis, Receivables - Accured has increased for eight consecutive quarters, with growth averaging 138.0% over the last eight quarters.
- Peak year-over-year performance for Receivables - Accured in the last five years was growth of 800.0% in Q4 2023, against a decline of 50.0% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.6 million (Q1 2026), $4.5 million (Q4 2025) and $3.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Spyre Therapeutics | 7.84 Bn | 7.84 Bn | - | 5.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.80 Mn |
| Mar 31, 2026 | 4.60 Mn |
| Dec 31, 2025 | 4.50 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 3.40 Mn |
| Dec 31, 2024 | 3.40 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 900,000.00 |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
API Access
Spyre Therapeutics Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();